-
Adriamycin, a mainstay in drug cancer treatment
Adriamycin is an anti-tumor antibiotic discovered in Italy, which has been and is still being used in a wide variety of tumors. The laboratory and the initial clinical studies leading to the demonstration of its usefulness were carried out in Italy.
Journalist:Silvio Monfardini
Date of publication:Read more17 May 2024
-
Platinum chemotherapy: a mainstay in drug treatment - Cisplatin
Chemotherapies are still essential to treat many cancer patients, and platinum-based drugs are among the most widely deployed. Successive generations of platinum agents are a European success story.
Journalist:Rachel Brazil
Date of publication:Read more14 September 2022
-
Platinum chemotherapy: a mainstay in drug treatment - Oxaliplatin
Chemotherapies are still essential to treat many cancer patients, and platinum-based drugs are among the most widely deployed. Successive generations of platinum agents are a European success story.
Journalist:Rachel Brazil
Date of publication:Read more06 September 2022
-
Platinum chemotherapy: a mainstay in drug treatment - Carboplatin
Chemotherapies are still essential to treat many cancer patients, and platinum-based drugs are among the most widely deployed. Successive generations of platinum agents are a European success story.
Journalist:Rachel Brazil
Date of publication:Read more21 July 2022